Covestor’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9K Sell
104
-6
-5% -$531 0.01% 1559
2026
Q2
$11K Buy
110
+102
+1,275% +$10.5K 0.01% 1526
2026
Q1
$1K Sell
8
-3
-27% -$286 ﹤0.01% 2078
2025
Q4
$1K Sell
11
-5
-31% -$430 ﹤0.01% 2104
2025
Q3
$1K Sell
16
-3
-16% -$268 ﹤0.01% 2120
2025
Q2
$2K Hold
19
– – ﹤0.01% 1857
2025
Q1
$2K Sell
19
-6
-24% -$558 ﹤0.01% 1858
2024
Q4
$2K Buy
25
+12
+92% +$1.15K ﹤0.01% 1897
2024
Q3
$1K Sell
13
-7
-35% -$607 ﹤0.01% 2027
2024
Q2
$2K Buy
20
+3
+18% +$220 ﹤0.01% 1866
2024
Q1
$1K Buy
17
+7
+70% +$432 ﹤0.01% 2020
2023
Q4
$1K Buy
10
+2
+25% +$105 ﹤0.01% 1996
2023
Q3
$0 Sell
8
-3
-27% -$178 ﹤0.01% 2431
2023
Q2
$1K Sell
11
-4
-27% -$244 ﹤0.01% 1970
2023
Q1
$1K Buy
15
+2
+15% +$97 ﹤0.01% 1867
2022
Q4
$1K Sell
13
-3
-19% -$140 ﹤0.01% 1894
2022
Q3
$1K Buy
16
+6
+60% +$300 ﹤0.01% 1815
2022
Q2
$0 Sell
10
-5
-33% -$224 ﹤0.01% 2158
2022
Q1
$1K Sell
15
-7
-32% -$313 ﹤0.01% 1875
2021
Q4
$1K Buy
+22
New +$1.14K ﹤0.01% 1819

Other funds holding LMAT

Covestor's LMAT Position: Q3 2026 in Review

Covestor reduced its LeMaitre Vascular (LMAT) stake by 5.5% in Q3 2026, selling an estimated $531 and leaving 104 shares worth $9K. The position accounts for 0.01% of the portfolio, ranked #1559.

Covestor first reported a position in LMAT in Q4 2021 and has held it in 20 quarters since. The position peaked at $11K in Q2 2026. 238 funds tracked by Wall St. Rank hold LMAT as of Q3 2026.

  • Covestor held 104 shares of LeMaitre Vascular worth $9K as of Q3 2026.
  • Covestor sold 6 LeMaitre Vascular shares in Q3 2026, an estimated $531.
  • LeMaitre Vascular made up 0.01% of Covestor's portfolio in Q3 2026, its #1559 holding.
  • Covestor first reported a position in LeMaitre Vascular in Q4 2021 and has held it in 20 quarters since.
  • Covestor's LeMaitre Vascular position peaked at $11K in Q2 2026.
  • 238 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.